流通市值:91.96亿 | 总市值:162.75亿 | ||
流通股本:7.01亿 | 总股本:12.40亿 |
报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 3,213,591,576.81 | 1,211,317,858.76 | 6,415,253,828.02 | 4,023,798,003.57 |
收到的税费返还 | 593,990.78 | 611,467.73 | 1,771,327.83 | 1,248,985.66 |
收到其他与经营活动有关的现金 | 156,246,702.08 | 118,130,937.52 | 240,198,852.3 | 156,121,480.84 |
经营活动现金流入小计 | 3,370,432,269.67 | 1,330,060,264.01 | 6,657,224,008.15 | 4,181,168,470.07 |
购买商品、接受劳务支付的现金 | 1,766,977,198.56 | 708,015,991.48 | 3,379,851,086.03 | 2,136,410,394.73 |
支付给职工以及为职工支付的现金 | 622,218,452.3 | 300,276,160.98 | 1,649,027,207.99 | 952,587,402.31 |
支付的各项税费 | 272,318,488.67 | 113,512,867.44 | 468,156,731.18 | 354,464,599.82 |
支付其他与经营活动有关的现金 | 178,311,519.09 | 177,364,909.06 | 494,229,731.75 | 414,324,364.75 |
经营活动现金流出小计 | 2,839,825,658.62 | 1,299,169,928.96 | 5,991,264,756.95 | 3,857,786,761.61 |
经营活动产生的现金流量净额 | 530,606,611.05 | 30,890,335.05 | 665,959,251.2 | 323,381,708.46 |
二、投资活动产生的现金流量: | ||||
收回投资收到的现金 | 66,000 | - | - | - |
取得投资收益收到的现金 | 16,845,197.38 | 1,299,990 | 30,364,076.52 | 28,884,653.19 |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 346,239.6 | 25,795.2 | 2,018,905.23 | 1,667,741.58 |
投资活动现金流入小计 | 17,257,436.98 | 1,325,785.2 | 32,382,981.75 | 30,552,394.77 |
购建固定资产、无形资产和其他长期资产支付的现金 | 71,263,152.24 | 38,608,723.07 | 285,417,624.89 | 122,815,848.76 |
投资支付的现金 | 0 | 94,838,090.4 | - | - |
取得子公司及其他营业单位支付的现金 | 244,619,168.34 | - | - | - |
投资活动现金流出小计 | 315,882,320.58 | 133,446,813.47 | 285,417,624.89 | 122,815,848.76 |
投资活动产生的现金流量净额 | -298,624,883.6 | -132,121,028.27 | -253,034,643.14 | -92,263,453.99 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | 0 | - | 4,500,000 | 4,500,000 |
其中:子公司吸收少数股东投资收到的现金 | 0 | - | 4,500,000 | - |
取得借款收到的现金 | 6,562,500 | - | 128,000,000 | 8,000,000 |
筹资活动现金流入平衡项目 | 0 | - | 0 | 0 |
筹资活动现金流入小计 | 6,562,500 | - | 132,500,000 | 12,500,000 |
偿还债务支付的现金 | 29,000,000 | 6,000,000 | 147,000,000 | 42,319,037.5 |
分配股利、利润或偿付利息支付的现金 | 29,547,800.78 | 1,369,892.22 | 305,061,535.98 | 295,160,766.43 |
其中:子公司支付给少数股东的股利、利润 | 22,613,735.55 | - | 35,585,626.91 | 35,065,519.16 |
支付其他与筹资活动有关的现金 | 17,547,643.7 | 2,597,628.43 | 12,145,383.55 | 16,436,036.52 |
筹资活动现金流出小计 | 76,095,444.48 | 9,967,520.65 | 464,206,919.53 | 353,915,840.45 |
筹资活动产生的现金流量净额 | -69,532,944.48 | -9,967,520.65 | -331,706,919.53 | -341,415,840.45 |
四、汇率变动对现金及现金等价物的影响 | -2,538,926.33 | -432,697.04 | -3,423,207.76 | -3,123,515.74 |
五、现金及现金等价物净增加额 | 159,909,856.64 | -111,630,910.91 | 77,794,480.77 | -113,421,101.72 |
加:期初现金及现金等价物余额 | 2,745,614,302.21 | 2,745,614,302.21 | 2,667,819,821.44 | 2,667,819,821.44 |
期末现金及现金等价物余额 | 2,905,524,158.85 | 2,633,983,391.3 | 2,745,614,302.21 | 2,554,398,719.72 |
补充资料: | ||||
净利润 | 440,391,500.57 | - | 762,623,628.5 | - |
资产减值准备 | 156,305.7 | - | 6,625,337.36 | - |
固定资产和投资性房地产折旧 | 124,932,407.39 | - | 221,361,137.79 | - |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 124,932,407.39 | - | 221,361,137.79 | - |
无形资产摊销 | 17,742,624.16 | - | 31,010,856.91 | - |
长期待摊费用摊销 | 1,027,616.78 | - | 5,489,795.42 | - |
处置固定资产、无形资产和其他长期资产的损失 | 1,643,164.6 | - | -962,342.62 | - |
固定资产报废损失 | 690,534.4 | - | 732,047.98 | - |
公允价值变动损失 | 0 | - | 3,828,908.42 | - |
财务费用 | 8,688,344.17 | - | 20,106,539.1 | - |
投资损失 | -16,564,738.59 | - | -38,970,546.53 | - |
递延所得税 | -5,524,831.77 | - | 2,950,125.22 | - |
其中:递延所得税资产减少 | -258,344.88 | - | -3,777,821.14 | - |
递延所得税负债增加 | -5,266,486.89 | - | 6,727,946.36 | - |
存货的减少 | -77,062,583.54 | - | 21,700,814.66 | - |
经营性应收项目的减少 | -1,089,792,459.75 | - | -428,137,917.02 | - |
经营性应付项目的增加 | 1,099,272,972.51 | - | 32,244,057.14 | - |
其他 | 13,796,610.32 | - | - | - |
现金的期末余额 | 2,905,524,158.85 | - | 2,745,614,302.21 | - |
减:现金的期初余额 | 2,745,614,302.21 | - | 2,667,819,821.44 | - |
现金及现金等价物的净增加额 | 159,909,856.64 | - | 77,794,480.77 | - |
公告日期 | 2025-08-29 | 2025-04-30 | 2025-03-29 | 2024-10-31 |
审计意见(境内) | 标准无保留意见 |